Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients

This article was originally published in The Gray Sheet

Executive Summary

Results of the highly anticipated COURAGE trial challenge the widespread assumption that stents improve outcomes in patients with stable coronary disease, but several observers believe the findings' impact on the stent market will be modest
Advertisement

Related Content

JAMA: Most PCI Appropriate, But Room For Improvement In Stable Patients
Drug-Eluting Stent Study: How Innovation Changes Care Patterns, Costs
Cardiologists Critique Consumer TV Advertising For Interventional Devices
Hospital Suppliers Show Vigor In ’07, With Prospects Strong For ’08 – Index
Follow-up Analyses Rekindle Debate On The Impact Of COURAGE
Cordis Consolidation Will Help J&J Save $1.6 Billion In 2008
Earnings Calls In Brief
Boston Scientific’s Improving ICD Sales Offset Slow Stent Revenues In Q1
Physicians Predict COURAGE Will Reduce U.S. Stent Procedures About 5%
New Data Is Likely To Add Fuel To The Drug-Eluting-Stent Debate
Advertisement
UsernamePublicRestriction

Register

MT024638

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel